Download PDF For Immediate Release Date: February 1, 2017 Contact: Thomas A. Schreck, Vice-Chairman SinuSys Corporation Phone: (650) 714-0445 SinuSys™ Corporation hires Bill Mavity as President & CEO PALO ALTO, Calif. — February 1, 2017 — SinuSys Corporation today announced the appointment of William G. (“Bill”) Mavity as the Company’s President and Chief Executive Officer... read more →
Download PDF For Immediate Release Date: July 13, 2016 Contact: Thomas A. Schreck, CEO SinuSys Corporation Phone: (650) 714-0445 SinuSys™ Corp. Receives FDA Clearance for the Vent-Os® Sinus Dilation Family of Devices PALO ALTO, Calif. — (BUSINESS WIRE) — SinuSys Corporation, an innovative sinus health company, today announced receipt of FDA clearance for a full.. read more →
Download PDF For Immediate Release Date: October 13, 2015 Contact: Michelle McAdam Chronic Communications Phone: (310) 902-1274 SinuSys Corp. to Support US Clinical Study of Next-Generation Steroid-Eluting Spacer Designed to Improve Outcomes for Functional Endoscopic Sinus Surgery (FESS) PALO ALTO, Calif. – October 13, 2015 – SinuSys Corp., an innovative sinus health company, today announced.. read more →
Download PDF For Immediate Release Date: June 30, 2015 Contact: Michelle McAdam Chronic Communications Phone: (310) 902-1274 SinuSys™ Corp. Receives CE Mark for Vent-Os® Sinus Dilation System for Treatment of Frontal and Sphenoid Sinusitis PALO ALTO, Calif. – June 30, 2015 – SinuSys Corp., an innovative sinus health company, today announced receipt of the CE.. read more →
Download PDF For Immediate Release Date: February 3, 2015 Contact: Michelle McAdam Chronic Communications Phone: (310) 902-1274 SinuSys Corp. to Support Clinical Study of New Steroid-Eluting Spacer Designed to Improve Sinus Surgery Outcomes PALO ALTO, Calif. – February 3, 2015 – SinuSys Corp., an innovative sinus health company, today announced commencement of a new clinical.. read more →
Date: October 21, 2014 From the October 10, 2014 issue of The MedTech Strategist, “SinuSys Finds Great Promise in Kinder, Gentler Sinusitis.” Next-generation interventional ENT company SinuSys reported positive data at one year from its clinical trial of Vent-Os, a new device therapy for chronic sinusitis. With a kinder and gentler therapy option, the company.. read more →
Download PDF For Immediate Release Date: September 22, 2014 Contact: Michelle McAdam Phone: (310) 902-1274 Innovative Vent-Os™ Sinus Dilation System Now Available in United States to Comfortably Treat Sinusitis in Doctor’s Office PALO ALTO, Calif. – September 22, 2014 – A new clinical study demonstrated that the Vent-Os™ Sinus Dilation System can unblock sinus passages.. read more →
Download PDF For Immediate Release Date: Sept 3, 2014 Contact: Michelle McAdam (310) 902-1274 SinuSys Corp. Names Robert Hoxie as Chief Commercial Officer PALO ALTO, Calif. – Sep 3, 2014 – SinuSys™ Corp., an innovative sinus health company, today announced that Robert Hoxie has joined the company as chief commercial officer, effective September 1. Mr... read more →
Download PDF For Immediate Release Date: May 15, 2014 Contact: Michelle McAdam (310) 902-1274 Positive Data for Innovative Sinusitis Device Presented at the Combined Otolaryngology Spring Meetings (COSM) PALO ALTO, Calif. – May 7, 2014 – SinuSys™ Corporation, an innovative sinus health company, today announced that the Vent-Os™ Sinus Dilation System demonstrated sustained patency of.. read more →
Download PDF For Immediate Release Date: January 7, 2014 Contact: Michelle McAdam (310) 902-1274 Unique Interventional Device is Designed to Simplify In-Office Treatment of Sinusitis PALO ALTO, Calif. – January 7, 2014 – SinuSys™ Corporation, an innovative sinus health company,today announced the Company has received FDA clearance for its Vent-Os™ Sinus Dilation System, designed to.. read more →
